Overview
Status
Suspended
Registry date
2018-02-15
Share capital
10,000.00 PLN
Registered address
ul. Wąwozowa 20/003, 02-796 Warszawa, Poland
Electronic delivery address
AE:PL-60207-51960-UHDHR-26
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 84 days early.
- 202516/03/2026
- 202417/03/2025
- 202311/06/2024
- 202217/04/2023
- 202127/06/2022
- 202018/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 242.25kMedianUSD 443.18kAverageUSD 1.74m
Net profit
This companyUSD -80.55kMedianUSD 14.27kAverageUSD 128.63k
Operating costs
This companyUSD 322.80kMedianUSD 395.77kAverageUSD 1.56m
Assets
This companyUSD 54.16kMedianUSD 173.69kAverageUSD 1.02m
Industry
Authorized Representatives
Jerzy Robert Brzozowski – President of the Management Board
Manner of representation
To make declarations of will, act on behalf of the company and represent the company, each member of the management board acting independently is authorized.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jerzy Robert Brzozowskiage 60 | 50 | $1,350.62 | 50% |
Anna Świątkowskaage 48 | 50 | $1,350.62 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nectar Polskasp. z o.o. | $528,123.00 | klinikametoda.pl | ||
| Astimedsp. z o.o. | $498,540.18 | astimed.pl | ||
| I. V. Clinicsp. z o.o. | $510,444.80 | ivclinic.com.pl | ||
| MAAMsp. z o.o. | $455,593.52 | urmed.pl | ||
| Saska Medsp. z o.o. | $241,826.45 | saskamed.pl | ||
| Promindsp. z o.o. | $89,181.48 | promindclinic.pl | ||
| Onkomedicasp. z o.o. | $69,344.55 | onkomedica.pl | ||
| Biocells Medicalsp. z o.o. | $11,508.17 | biocellsmedical.com | ||
| Bodyclinicsp. z o.o. | $3,758.46 | bodyclinic.pl | ||
| Regenerumclinicsp. z o.o. | $1,427.86 | regenerumclinic.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-04-30 | Business suspended | |
| 2021-12-13 | Address change (Ul. Prymasa Augusta Hlonda 4g/16, 02-972, Warszawa → Ul. Wąwozowa 20/003, 02-796, Warszawa) | |
| 2018-02-15 | Entered in the register |
FAQ
The main business activity of K2 Med focuses on specialist medical practice activities.
The company was registered in the Polish National Court Register (KRS) on February 15, 2018.
The headquarters is located at: ul. Wąwozowa 20, 02-796 Warszawa.
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $242,251, representing a decrease of 18.6% compared to 2024.
No, the company recorded a net loss of $80,551 in 2025.
The largest operating cost category falls under other operating costs. This category amounted to $199,927 in 2025, representing 62% of all operating expenses.
Last updated: 2026-05-04
